Patents Assigned to MAX-DELRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN - Justia Patents Search

Patents Assigned to MAX-DELRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN

Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases

Patent number: 10189906

Abstract: The invention relates to antibodies or antibody fragments that bind CD269 (BCMA), thereby disrupting the interaction between CD269 and its native ligands (BAFF and APRIL), and their use in the treatment of plasma cell-mediated diseases such as multiple myeloma and autoimmune diseases.

Type: Grant

Filed: November 1, 2013

Date of Patent: January 29, 2019

Assignee: MAX-DELRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN

Inventors: Martin Lipp, Felix Oden, Uta Höpken, Gerd Müller, Oliver Daumke, Stephen Marino, Daniel Olal